Clinical Trials Browser

OTHER × Locally Advanced Low Rectal Adenocarcinoma × spartalizumab × Clear all

NCT07277842 2025-12-11

PD-1 + FOLFOXIRI vs CAPOX as Total Neoadjuvant Therapy for pMMR Low Rectal Cancer

Phase 3 Not yet recruiting

Gastrointestinal

Locally Advanced Low Rectal Adenocarcinoma